MANUEL PRAGA TERENTE-rekin lankidetzan egindako argitalpenak (15)

2023

  1. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876

  2. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis

    Nefrologia, Vol. 43, Núm. 1, pp. 6-47

2022

  1. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303

2021

  1. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

2020

  1. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2019

  1. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139

  2. IgA nephropathy in elderly patients

    Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 8, pp. 1183-1192

2018

  1. Changes in the clinical presentation of immunoglobulin A nephropathy: Data from the Spanish Registry of Glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 3, pp. 472-477

2015

  1. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 3, pp. 467-474

2014

  1. Microhematuria persistente con proteinuria negativa o de escasa cuantía

    Nefrologia, Vol. 34, Núm. 1, pp. 110-114

2013

  1. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 11, pp. 1870-1876

  2. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: A randomized trial

    American Journal of Kidney Diseases, Vol. 61, Núm. 2, pp. 211-218

2012

  1. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

    Journal of the American Society of Nephrology, Vol. 23, Núm. 10, pp. 1753-1760

2008

  1. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis

    Kidney International, Vol. 73, Núm. 8, pp. 940-946

2006

  1. Dual blockade of the renin-angiotensin system in the progression of renal disease: The need for more clinical trials

    Journal of the American Society of Nephrology